Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $6.04 USD
Change Today -0.03 / -0.49%
Volume 5.1K
As of 8:10 PM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

mgc diagnostics corp (MGCD) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/4/14 - $9.55
52 Week Low
12/29/14 - $5.51
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MGC DIAGNOSTICS CORP (MGCD)

Related News

No related news articles were found.

mgc diagnostics corp (MGCD) Related Businessweek News

No Related Businessweek News Found

mgc diagnostics corp (MGCD) Details

MGC Diagnostics Corporation researches, develops, manufactures, and markets non-invasive cardiorespiratory diagnostic products under the MGC Diagnostics and MediSoft brand and trade names in the United States and internationally. It primarily offers pulmonary function products that include Spirometry, Complete Pulmonary Function Ultima PF, and Body Plethysmography product categories, which enable the early detection of lung disease; evaluating the effect of medication; monitoring patients with chronic disease; diagnosing lung diseases, such as asthma, emphysema, and bronchitis/chronic obstructive pulmonary disease; managing treatment; assessing the surgical risk of lung transplant and lung reduction candidates; and evaluating the impact of diseases, such as neuromuscular disease on breathing. The company also provides cardiopulmonary exercise testing products that measure functional capacity, fitness, or conditioning levels; and evaluate prognostic criteria for surgical procedures, as well as help physicians diagnose heart and lung diseases. In addition, it offers cycle ergometers and treadmills for use in diagnostic, rehabilitation, and sports medicine applications; and electronic medical records interfaces, such as HL7 interface technology software, installation, and support for data communication interfaces. MGC Diagnostics Corporation sells its products through a direct sales force and distributors to hospitals, university-based medical centers, medical clinics, physician offices, pharmaceutical companies, medical device manufacturers, and clinical research organizations. The company was formerly known as Angeion Corporation and changed its name to MGC Diagnostics Corporation in August 2012. MGC Diagnostics Corporation was founded in 1986 and is headquartered in Saint Paul, Minnesota.

158 Employees
Last Reported Date: 01/29/15
Founded in 1986

mgc diagnostics corp (MGCD) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: $255.3K
Total Annual Compensation: $249.2K
Chief Financial Officer and Chief Operating O...
Total Annual Compensation: $227.1K
Compensation as of Fiscal Year 2014.

mgc diagnostics corp (MGCD) Key Developments

MGC Diagnostics Corporation Announces Newly Repackaged Ultima Series

MGC Diagnostics Corporation announced the release of its latest design of the Ultima Series cardiorespiratory diagnostic system, capable of performing both pulmonary function and metabolic testing in a single, modular, upgradeable platform, utilizing the latest technology. The system will be featured at the upcoming American Thoracic Society Meeting along with the full MGC Diagnostics Medical Graphics product line.

MGC Diagnostics Corporation Reports Unaudited Consolidated Earnings Results for the First Quarter Ended January 31, 2015

MGC Diagnostics Corporation reported unaudited consolidated earnings results for the first quarter ended January 31, 2015. For the quarter, the company reported net loss of $541,000 or $0.13 per basic and diluted share on revenues of $8,943,000 against net loss of $243,000 or $0.06 per basic and diluted share on revenues of $6,304,000 a year ago. Operating income of $100,000 compared to operating loss of $226,000 a year ago. Loss before taxes of $682,000 compared to $226,000 a year ago. Net cash provided by operating activities was $12,000 compared to $880,000 a year ago. Purchases of property and equipment and intangible assets of $176,000 compared to $369,000 a year ago. The net loss was principally caused by a non-cash, foreign currency translation loss of $724,000.

MGC Diagnostics Corporation to Report Q1, 2015 Results on Mar 05, 2015

MGC Diagnostics Corporation announced that they will report Q1, 2015 results at 11:00 AM, US Eastern Standard Time on Mar 05, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MGCD:US $6.04 USD -0.03

MGCD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bovie Medical Corp $2.89 USD 0.00
IRIDEX Corp $8.38 USD -0.32
Misonix Inc $10.90 USD -0.47
Synergetics USA Inc $4.42 USD 0.00
Utah Medical Products Inc $54.73 USD +1.02
View Industry Companies

Industry Analysis


Industry Average

Valuation MGCD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.8x
Price/Book 1.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MGC DIAGNOSTICS CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at